microdosing semaglutide menopause GLP-1s: A New Approach to Hormonal and Metabolic Balance in Midlife Microdosing GLP-1 for Perimenopause: Why

Patients may need a more careful discussion if they have a history of: Previous NAION in one eye Significant optic nerve crowding Diabetes with vascular complications Sleep apnea, especially untreated sleep apnea High blood pressure or low nighttime blood pressure Cardiovascular disease Sudden unexplained vision loss in the past This does not automatically mean a GLP-1 medication is unsafe, but it does mean the patient should have a personalized risk-benefit discussion with their medical provider

If semaglutide is not producing sufficient results and you want something available today, tirzepatide is the logical next step before retatrutide reaches the market

These usually improve within the first few weeks

Medication effects also appeared stronger with increasing doses

The goal isnt just to eat lessits to nourish your body well while your appetite is naturally smaller